Publication | Closed Access

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

UrologyOpen LabelGenitourinary CancerMedicineCancer ManagementInterim ResultsCancer TreatmentOncologyRadiation OncologyMolecular Oncology